• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性肌营养不良——一种早老性疾病?

Myotonic Dystrophy-A Progeroid Disease?

作者信息

Meinke Peter, Hintze Stefan, Limmer Sarah, Schoser Benedikt

机构信息

Friedrich-Baur-Institute at the Department of Neurology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

出版信息

Front Neurol. 2018 Jul 25;9:601. doi: 10.3389/fneur.2018.00601. eCollection 2018.

DOI:10.3389/fneur.2018.00601
PMID:30140252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6095001/
Abstract

Myotonic dystrophies (DM) are slowly progressing multisystemic disorders caused by repeat expansions in the or genes. The multisystemic involvement in DM patients often reflects the appearance of accelerated aging. This is partly due to visible features such as cataracts, muscle weakness, and frontal baldness, but there are also less obvious features like cardiac arrhythmia, diabetes or hypogammaglobulinemia. These aging features suggest the hypothesis that DM could be a segmental progeroid disease. To identify the molecular cause of this characteristic appearance of accelerated aging we compare clinical features of DM to "typical" segmental progeroid disorders caused by mutations in DNA repair or nuclear envelope proteins. Furthermore, we characterize if this premature aging effect is also reflected on the cellular level in DM and investigate overlaps with "classical" progeroid disorders. To investigate the molecular similarities at the cellular level we use primary DM and control cell lines. This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope. Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder.

摘要

强直性肌营养不良症(DM)是由 或 基因中的重复序列扩增引起的缓慢进展的多系统疾病。DM患者的多系统受累往往反映出加速衰老的表现。这部分是由于白内障、肌肉无力和前额秃发等明显特征,但也有不太明显的特征,如心律失常、糖尿病或低丙种球蛋白血症。这些衰老特征提示了一个假说,即DM可能是一种节段性早老样疾病。为了确定这种加速衰老特征性表现的分子原因,我们将DM的临床特征与由DNA修复或核膜蛋白突变引起的“典型”节段性早老样疾病进行比较。此外,我们还确定这种早衰效应在DM的细胞水平上是否也有体现,并研究与“经典”早老样疾病的重叠情况。为了在细胞水平上研究分子相似性,我们使用原发性DM细胞系和对照细胞系。该分析揭示了与核膜相关的早老样综合征有许多相似之处。我们在临床和分子水平上的比较支持将DM定性为节段性早老样疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/ce675e908167/fneur-09-00601-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/3dc8aaefc3ec/fneur-09-00601-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/aded429a2498/fneur-09-00601-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/ad266e35a068/fneur-09-00601-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/33b05d8fc1ea/fneur-09-00601-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/ce675e908167/fneur-09-00601-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/3dc8aaefc3ec/fneur-09-00601-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/aded429a2498/fneur-09-00601-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/ad266e35a068/fneur-09-00601-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/33b05d8fc1ea/fneur-09-00601-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b946/6095001/ce675e908167/fneur-09-00601-g0005.jpg

相似文献

1
Myotonic Dystrophy-A Progeroid Disease?强直性肌营养不良——一种早老性疾病?
Front Neurol. 2018 Jul 25;9:601. doi: 10.3389/fneur.2018.00601. eCollection 2018.
2
Muscle wasting in myotonic dystrophies: a model of premature aging.强直性肌营养不良症中的肌肉萎缩:早衰模型。
Front Aging Neurosci. 2015 Jul 9;7:125. doi: 10.3389/fnagi.2015.00125. eCollection 2015.
3
Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.强直性肌营养不良症中骨骼肌肌生成、生长及再生的异常情况。
Front Neurol. 2018 May 28;9:368. doi: 10.3389/fneur.2018.00368. eCollection 2018.
4
Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics.
J Cell Physiol. 1981 May;107(2):255-60. doi: 10.1002/jcp.1041070212.
5
[Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].[强直性肌营养不良症(DM/屈施曼-施泰纳特病)和近端强直性肌病(PROMM/里克综合征)。具有多系统表现的强直性肌病]
Nervenarzt. 2001 Aug;72(8):618-24. doi: 10.1007/s001150170061.
6
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.2型强直性肌营养不良症原代肌肉培养物中的早衰与p16诱导无关。
Eur J Histochem. 2014 Oct 22;58(4):2444. doi: 10.4081/ejh.2014.2444.
7
Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.强直性肌营养不良症:临床方面、遗传学、病理学及分子发病机制的最新进展
Biochim Biophys Acta. 2015 Apr;1852(4):594-606. doi: 10.1016/j.bbadis.2014.05.019. Epub 2014 May 29.
8
Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.近端肌强直性肌病。一种类似于强直性肌营养不良的多系统疾病的临床特征。
Arch Neurol. 1995 Jan;52(1):25-31. doi: 10.1001/archneur.1995.00540250029009.
9
Myotonic dystrophy and myotonic dystrophy protein kinase.强直性肌营养不良症与强直性肌营养不良蛋白激酶
Prog Histochem Cytochem. 2000;35(3):187-251. doi: 10.1016/s0079-6336(00)80002-9.
10
Identification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotype.对具有强直性肌营养不良样表型患者的MBNL1基因变异进行鉴定。
Eur J Hum Genet. 2016 Oct;24(10):1467-72. doi: 10.1038/ejhg.2016.41. Epub 2016 May 25.

引用本文的文献

1
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.1型强直性肌营养不良的多系统症状:管理与治疗视角
Int J Mol Sci. 2025 Jun 2;26(11):5350. doi: 10.3390/ijms26115350.
2
The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2.CNBP在脑萎缩中的作用及其在2型强直性肌营养不良中的靶向作用。
Hum Mol Genet. 2025 Mar 7;34(6):512-522. doi: 10.1093/hmg/ddaf002.
3
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.1型强直性肌营养不良的新视野:细胞衰老作为治疗靶点

本文引用的文献

1
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.基于英国临床实践研究数据链接中的初级保健医生数据,1 型肌强直性营养不良患者的皮肤癌风险。
Int J Cancer. 2018 Mar 15;142(6):1174-1181. doi: 10.1002/ijc.31143. Epub 2017 Nov 20.
2
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.评估年龄和性别对 2 型肌强直性营养不良表型的影响。
J Neurol. 2017 Dec;264(12):2472-2480. doi: 10.1007/s00415-017-8653-2. Epub 2017 Oct 30.
3
[Lamin B1 and lamin B2 in human skin in the process of aging].
Bioessays. 2025 Mar;47(3):e202400216. doi: 10.1002/bies.202400216. Epub 2024 Dec 26.
4
A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1.一类新型FKBP12配体可挽救与1型强直性肌营养不良相关的早衰表型。
Cells. 2024 Nov 22;13(23):1939. doi: 10.3390/cells13231939.
5
Common Characteristics Between Frailty and Myotonic Dystrophy Type 1: A Narrative Review.脆弱与1型强直性肌营养不良之间的共同特征:一篇叙述性综述。
Aging Dis. 2024 Aug 29;16(4):2120-2131. doi: 10.14336/AD.2024.0950.
6
Characterization of the neuropathic pain component contributing to myalgia in patients with myotonic dystrophy type 1 and 2.1型和2型强直性肌营养不良患者中导致肌痛的神经性疼痛成分的特征分析
Front Neurol. 2024 Aug 13;15:1414140. doi: 10.3389/fneur.2024.1414140. eCollection 2024.
7
Small and large fiber neuropathy in adults with myotonic dystrophy type 1.1型强直性肌营养不良成年患者的小纤维和大纤维神经病变
Front Neurol. 2024 Mar 5;15:1375218. doi: 10.3389/fneur.2024.1375218. eCollection 2024.
8
Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.衰老细胞清除剂清除有缺陷的肌肉干细胞可恢复肌强直性营养不良 1 型的肌生成。
Nat Commun. 2023 Jul 19;14(1):4033. doi: 10.1038/s41467-023-39663-3.
9
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).肌强直性营养不良 1 型(DM1)中枢神经系统(CNS)受累的液体生物标志物。
Int J Mol Sci. 2023 Jan 22;24(3):2204. doi: 10.3390/ijms24032204.
10
Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle.参与基因组组织的核膜跨膜蛋白在1型强直性肌营养不良症肌肉中表达失调。
Front Cell Dev Biol. 2023 Jan 9;10:1007331. doi: 10.3389/fcell.2022.1007331. eCollection 2022.
Adv Gerontol. 2016;29(2):222-228.
4
Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis.1型和2型强直性肌营养不良的皮肤特征:早衰和维生素D稳态的影响
Neuromuscul Disord. 2017 Feb;27(2):163-169. doi: 10.1016/j.nmd.2016.11.004. Epub 2016 Nov 16.
5
WRN regulates pathway choice between classical and alternative non-homologous end joining.WRN 调控经典非同源末端连接和替代性非同源末端连接之间的通路选择。
Nat Commun. 2016 Dec 6;7:13785. doi: 10.1038/ncomms13785.
6
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy.p21(WAF1)介导细胞周期抑制,与癌症抑制和治疗相关。
Cancer Res. 2016 Sep 15;76(18):5189-91. doi: 10.1158/0008-5472.CAN-16-2055.
7
A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients.MSH3错配修复基因中的一种多态性与1型强直性肌营养不良患者血液DNA中CTG重复序列扩增的体细胞不稳定性水平相关。
DNA Repair (Amst). 2016 Apr;40:57-66. doi: 10.1016/j.dnarep.2016.01.001. Epub 2016 Mar 8.
8
Barrier-to-autointegration factor (BAF) involvement in prelamin A-related chromatin organization changes.屏障自整合因子(BAF)参与前层粘连蛋白A相关的染色质组织变化。
Oncotarget. 2016 Mar 29;7(13):15662-77. doi: 10.18632/oncotarget.6697.
9
Muscle wasting in myotonic dystrophies: a model of premature aging.强直性肌营养不良症中的肌肉萎缩:早衰模型。
Front Aging Neurosci. 2015 Jul 9;7:125. doi: 10.3389/fnagi.2015.00125. eCollection 2015.
10
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.2型强直性肌营养不良症原代肌肉培养物中的早衰与p16诱导无关。
Eur J Histochem. 2014 Oct 22;58(4):2444. doi: 10.4081/ejh.2014.2444.